Upacicalcet sodium
Modify Date: 2024-01-10 18:52:46
Upacicalcet sodium structure
|
Common Name | Upacicalcet sodium | ||
|---|---|---|---|---|
| CAS Number | 2052969-18-1 | Molecular Weight | 373.75 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C11H13ClN3NaO6S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Upacicalcet sodiumUpacicalcet sodium is an intravenous calcimimetic agent. Upacicalcet suppresses excessive parathyroid hormone (PTH) secretion, thereby lowering blood PTH levels, by acting directly on parathyroid cell membrane calcium-sensing receptors. Upacicalcet can be used for researching the disease of secondary hyperparathyroidism (SHPT)[1]. |
| Name | Upacicalcet sodium |
|---|
| Description | Upacicalcet sodium is an intravenous calcimimetic agent. Upacicalcet suppresses excessive parathyroid hormone (PTH) secretion, thereby lowering blood PTH levels, by acting directly on parathyroid cell membrane calcium-sensing receptors. Upacicalcet can be used for researching the disease of secondary hyperparathyroidism (SHPT)[1]. |
|---|---|
| Related Catalog | |
| Target |
calcium-sensing receptors[1] |
| References |
[1]. Hoy SM. Upacicalcet: First Approval. Drugs. 2021;81(13):1593-1596. |
| Molecular Formula | C11H13ClN3NaO6S |
|---|---|
| Molecular Weight | 373.75 |